309 related articles for article (PubMed ID: 23708585)
41. Specific keratinase derived designer peptides potently inhibit A
Rajput R; G L B; Srivastava A; Wahi D; Shrivastava N; Kundu B; Grover A
Biochem J; 2019 Jun; 476(12):1817-1841. PubMed ID: 31138770
[TBL] [Abstract][Full Text] [Related]
42. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
Jin Y; Sun Y; Lei J; Wei G
Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
[TBL] [Abstract][Full Text] [Related]
43. Computational approach for the assessment of inhibitory potency against beta-amyloid aggregation.
Bajda M; Filipek S
Bioorg Med Chem Lett; 2017 Jan; 27(2):212-216. PubMed ID: 27914799
[TBL] [Abstract][Full Text] [Related]
44. Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.
Lemkul JA; Bevan DR
Biochemistry; 2010 May; 49(18):3935-46. PubMed ID: 20369844
[TBL] [Abstract][Full Text] [Related]
45. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
46. Polymorphic structures of Alzheimer's β-amyloid globulomers.
Yu X; Zheng J
PLoS One; 2011; 6(6):e20575. PubMed ID: 21687730
[TBL] [Abstract][Full Text] [Related]
47. Molecular structure of the NQTrp inhibitor with the Alzheimer Aβ1-28 monomer.
Tarus B; Nguyen PH; Berthoumieu O; Faller P; Doig AJ; Derreumaux P
Eur J Med Chem; 2015 Feb; 91():43-50. PubMed ID: 25011560
[TBL] [Abstract][Full Text] [Related]
48. Combined experimental and simulation studies suggest a revised mode of action of the anti-Alzheimer disease drug NQ-Trp.
Berthoumieu O; Nguyen PH; Castillo-Frias MP; Ferre S; Tarus B; Nasica-Labouze J; Noël S; Saurel O; Rampon C; Doig AJ; Derreumaux P; Faller P
Chemistry; 2015 Sep; 21(36):12657-66. PubMed ID: 26179053
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of fiber assembly: treatment of Aβ peptide aggregation with a coarse-grained united-residue force field.
Rojas A; Liwo A; Browne D; Scheraga HA
J Mol Biol; 2010 Dec; 404(3):537-52. PubMed ID: 20888834
[TBL] [Abstract][Full Text] [Related]
50. Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes.
Tofoleanu F; Buchete NV
J Mol Biol; 2012 Aug; 421(4-5):572-86. PubMed ID: 22281438
[TBL] [Abstract][Full Text] [Related]
51. Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.
Kahler A; Sticht H; Horn AH
PLoS One; 2013; 8(7):e70521. PubMed ID: 23936224
[TBL] [Abstract][Full Text] [Related]
52. Probing amyloid-beta fibril stability by increasing ionic strengths.
Zidar J; Merzel F
J Phys Chem B; 2011 Mar; 115(9):2075-81. PubMed ID: 21329333
[TBL] [Abstract][Full Text] [Related]
53. The effect of curcumin on the stability of Aβ dimers.
Zhao LN; Chiu SW; Benoit J; Chew LY; Mu Y
J Phys Chem B; 2012 Jun; 116(25):7428-35. PubMed ID: 22690789
[TBL] [Abstract][Full Text] [Related]
54. Insights into the aggregation mechanism of Aβ(25-40).
Xiong J; JiJi RD
Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
[TBL] [Abstract][Full Text] [Related]
55. Light-controlled toxicity of engineered amyloid β-peptides.
Hoppmann C; Barucker C; Lorenz D; Multhaup G; Beyermann M
Chembiochem; 2012 Dec; 13(18):2657-60. PubMed ID: 23161824
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of antineurotoxicity properties of an amyloid-β peptide targeting ligand containing a triamino acid.
Honcharenko D; Bose PP; Maity J; Kurudenkandy FR; Juneja A; Flöistrup E; Biverstål H; Johansson J; Nilsson L; Fisahn A; Strömberg R
Org Biomol Chem; 2014 Sep; 12(34):6684-93. PubMed ID: 25030615
[TBL] [Abstract][Full Text] [Related]
57. Investigation of the effect of erythrosine B on amyloid beta peptide using molecular modeling.
Lee J; Kwon I; Jang SS; Cho AE
J Mol Model; 2016 Apr; 22(4):92. PubMed ID: 27021211
[TBL] [Abstract][Full Text] [Related]
58. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce "off-pathway" structures.
Lemkul JA; Bevan DR
Biochemistry; 2012 Jul; 51(30):5990-6009. PubMed ID: 22762350
[TBL] [Abstract][Full Text] [Related]
59. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
60. A solution NMR toolset to probe the molecular mechanisms of amyloid inhibitors.
Ahmed R; Melacini G
Chem Commun (Camb); 2018 May; 54(37):4644-4652. PubMed ID: 29658548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
